Stay updated on Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial

Sign up to get notified when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Locations section with the Pittsburgh, PA site and updated the page revision to v3.3.3; removed the HHS Vulnerability Disclosure and the previous Pennsylvania Locations reference.
    Difference
    0.2%
    Check dated 2025-12-23T09:45:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:56:56.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the notice about lapse in government funding and operating status from the page; this is maintenance content and does not alter the study details or data presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T14:59:07.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The new screenshot shows only cosmetic styling and layout adjustments; core study data and sections (Overview, Eligibility Criteria, Outcomes, and Study Record Dates) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:32:35.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If there are no other changes, this is the main shift.
    Difference
    5%
    Check dated 2025-10-05T10:35:30.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Standardize disease naming to 'Hemophilia A' and increment the version to v3.1.0; no major substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:29:09.000Z thumbnail image

Stay in the know with updates to Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.